Tudor Investment Corp’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.36M | Buy |
124,068
+32,736
| +36% | +$1.41M | 0.01% | 563 |
|
|
2025
Q1 | $3.16M | Buy |
+91,332
| New | +$3.16M | 0.01% | 637 |
|
|
2024
Q2 | – | Sell |
-22,164
| Closed | -$685K | – | 1516 |
|
|
2024
Q1 | $685K | Buy |
+22,164
| New | +$685K | ﹤0.01% | 1011 |
|
|
2023
Q4 | – | Sell |
-81,150
| Closed | -$2.14M | – | 1488 |
|
|
2023
Q3 | $2.14M | Buy |
+81,150
| New | +$2.14M | 0.02% | 625 |
|
|
2023
Q2 | – | Sell |
-23,321
| Closed | -$387K | – | 1542 |
|
|
2023
Q1 | $387K | Sell |
23,321
-51,187
| -69% | -$849K | 0.01% | 1204 |
|
|
2022
Q4 | $568K | Sell |
74,508
-5,218
| -7% | -$39.8K | 0.01% | 1076 |
|
|
2022
Q3 | $792K | Buy |
+79,726
| New | +$792K | 0.02% | 916 |
|
|
2022
Q1 | – | Sell |
-120,372
| Closed | -$2.01M | – | 1537 |
|
|
2021
Q4 | $2.01M | Buy |
120,372
+29,679
| +33% | +$495K | 0.03% | 580 |
|
|
2021
Q3 | $4.25M | Buy |
90,693
+43,630
| +93% | +$2.05M | 0.07% | 272 |
|
|
2021
Q2 | $2.87M | Buy |
+47,063
| New | +$2.87M | 0.05% | 387 |
|